A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...

A federal jury in California ruled Friday that Apple must pay medical device maker Masimo $634 million for infringing a patent on blood oxygen-monitoring technology. Reuters reports the jury found ...

Masimo found out about restoration of pulse oximetry to the Apple Watch the same way that the rest of the world did, and is suing US Customs and Border Protection to stop the process. It seems Apple ...

Apple will be rolling out a redesigned version of the feature to the Series 9, 10 and Ultra 2 today. Apple will be rolling out a redesigned version of the feature to the Series 9, 10 and Ultra 2 today ...

In early 2024, Apple removed a blood oxygen monitoring feature from its then-current Apple Watch Series 9 and Ultra 2 watches, following a ruling that the feature violated light-based pulse oximetry ...

Apple removed blood oxygen monitoring from the Apple Watch in early 2024. Somebody has to blink for it to return, and it looks like neither Masimo nor Apple are going to budge. Blood oxygen monitoring ...

Apple is now planning to appeal an infamous ban that led to the Apple Watch Series 9 and Ultra 2 versions losing the blood oxygen sensor feature last year in court. The case saw the International ...

The electrochemical sensors developed in Ariel Furst’s lab consist of DNA adhered to an inexpensive gold leaf electrode, which is laminated onto a sheet of plastic. CAMBRIDGE, MA -- Using an ...

Forget the so-called 'Pulsed-Field Ablation Wars'—competition in the continuous glucose monitor (CGM) market is just as fierce. There have been several key approvals in the space, and on Monday, ...